Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Blinatumomab
Related studies linked through entity extraction aliases.
Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot
- Status
- RECRUITING
- Phase
- NA
Study in Adult Ph-positive ALL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Blinatumomab Bridging Therapy for BALL
- Status
- TERMINATED
- Phase
- PHASE2
Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE4
Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL
- Status
- WITHDRAWN
- Phase
- PHASE2
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study
- Status
- UNKNOWN
- Phase
- PHASE2
Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Status
- RECRUITING
- Phase
- PHASE3
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- Status
- RECRUITING
- Phase
- PHASE1
Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Status
- RECRUITING
- Phase
- PHASE3
BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2